MCL-1 is a clinically targetable vulnerability in breast cancer

Winder, M. L. and Campbell, K. J. (2022) MCL-1 is a clinically targetable vulnerability in breast cancer. Cell Cycle, pp. 1-17. (doi: 10.1080/15384101.2022.2054096)

Full text not currently available from Enlighten.


Item Type:Articles
Additional Information:** From Crossref journal articles via Jisc Publications Router ** History: epub 29-03-2022; issued 29-03-2022.
Keywords:Cell Biology, Developmental Biology, Molecular Biology
Status:Published
Glasgow Author(s) Enlighten ID:UNSPECIFIED
Authors: Winder, M. L., and Campbell, K. J.
College/School:UNSPECIFIED
Journal Name:Cell Cycle
Publisher:Informa UK Limited
ISSN:1551-4005

University Staff: Request a correction | Enlighten Editors: Update this record